An update on susceptibility‐weighted imaging in brain gliomas
European Radiology · 06.04.2024 · 34 (10) · 6763-6775
DOI: 10.1007/s00330-024-10703-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Radiology, online erschienen am 06.04.2024. Verfasst von Teodoro Martín-Noguerol und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRI Unit, Radiology Department, HT Medica, Carmelo Torres 2, 23007, Jaén, Spain. t.martin.f@htime.org. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Magnetic Resonance Imaging, Contrast Media. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Susceptibility-weighted imaging (SWI) has become a standard component of most brain MRI protocols. While traditionally used for detecting and characterising brain hemorrhages typically associated with stroke or trauma, SWI has also shown promising results in glioma assessment. Numerous studies have highlighted SWI's role in differentiating gliomas from other brain lesions, such as primary central nervous system lymphomas or metastases. Additionally, SWI aids radiologists in non-invasively grading gliomas and predicting their phenotypic profiles. Various researchers have suggested incorporating SWI as an adjunct sequence for predicting treatment response and for post-treatment monitoring. A significant focus of these studies is on the detection of intratumoural susceptibility signals (ITSSs) in gliomas, which are indicative of microhemorrhages and vessels within the tumour. The quantity, distribution, and characteristics of these ITSSs can provide radiologists with more precise information for evaluating and characterising gliomas. Furthermore, the potential benefits and added value of performing SWI after the administration of gadolinium-based contrast agents (GBCAs) have been explored. This review offers a comprehensive, educational, and practical overview of the potential applications and future directions of SWI in the context of glioma assessment. CLINICAL RELEVANCE STATEMENT: SWI has proven effective in evaluating gliomas, especially through assessing intratumoural susceptibility signal changes, and is becoming a promising, easily integrated tool in MRI protocols for both pre- and post-treatment assessments. KEY POINTS: • Susceptibility-weighted imaging is the most sensitive sequence for detecting blood and calcium inside brain lesions. • This sequence, acquired with and without gadolinium, helps with glioma diagnosis, characterisation, and grading through the detection of intratumoural susceptibility signals. • There are ongoing challenges that must be faced to clarify the role of susceptibility-weighted imaging for glioma assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRI Unit, Radiology Department, HT Medica, Carmelo Torres 2, 23007, Jaén, Spain. t.martin.f@htime.org.
- Department of Radiology, Povisa Hospital (Ribera Salud Group), Vigo, Spain.
- Department of Neuroradiology, University Hospital, 12 de Octubre, Madrid, Spain.
- MRI Unit, Radiology Department, HT Medica, Carmelo Torres 2, 23007, Jaén, Spain.
Zitieren
APA
Martín-Noguerol, T., Santos-Armentia, E., Ramos, A., & Luna, A. (2024). An update on susceptibility‐weighted imaging in brain gliomas. European Radiology, 34(10), 6763-6775. https://doi.org/10.1007/s00330-024-10703-w
Vancouver
Martín-Noguerol T, Santos-Armentia E, Ramos A, Luna A. An update on susceptibility‐weighted imaging in brain gliomas. European Radiology. 2024;34(10):6763-6775. doi:10.1007/s00330-024-10703-w
BibTeX
@article{MartnNoguerol2024,
author = {Martín-Noguerol, Teodoro and Santos-Armentia, Eloísa and Ramos, Ana and Luna, Antonio},
title = {An update on susceptibility‐weighted imaging in brain gliomas},
journal = {European Radiology},
year = {2024},
volume = {34},
number = {10},
pages = {6763--6775},
doi = {10.1007/s00330-024-10703-w}
}
EUVIMED